![Finn M. Ulrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Finn M.
Ulrich joined Millimed A/S in September 2004 and currently serves as Vice President of Research and Development.
Previously, he was Director of Medical Device Operations for Novo Nordisk A/S from 1996 to 2001 and Project Director of Research and Development from 2001 to 2004.
Before joining Novo Nordisk, Mr. Ulrich was Engineer of Research and Development for Brüel & Kjær A/S from 1986 to 1991.
He has research and development, manufacturing, quality assurance, and pharmaceutical engineering in the medtech industry.
Mr. Ulrich received a Bachelor of Commerce degree from the Copenhagen Business School Finn and a Master of Science degree in Electronical Engineering from the Technical University of Denmark.
Precedenti posizioni note di Finn M. Ulrich
Società | Posizione | Fine |
---|---|---|
Millimed A/S
![]() Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Direttore Tecnico/Scientifico/R&S | 25/06/2009 |
NOVO NORDISK A/S | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Aziende private | 1 |
---|---|
Millimed A/S
![]() Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Health Services |
- Borsa valori
- Insiders
- Finn M. Ulrich